IGC Pharma (IGC) Live Share Price, Invest From India

IGC Pharma Stock Performance

as on September 26, 2026 at 2:15 pm IST

Day's Low
Day's High
$0.28
Day's Price Range
$0.29
$0.28
0.85%
Downside
2.69%
Upside
52 Week's Low
52 Week's High
$0.24
52-Week Price Range
$0.45
$0.28
16.78%
Downside
59.63%
Upside

IGC Pharma share price movements today

Previous Close: $0.28
Open: $0.28
Volume: 5.1M
Market Cap: $29.1M
Day's Low - High: $0.28 - $0.29
52 Week Low - High: $0.24 - $0.45

IGC Pharma Historical Returns

1 Month Return: -8.22 %
3 Month Return: + 7.38 %
1 Year Return: -28.99 %
3 Year Return: -17.52 %
5 Year Return: -81.54 %

IGC Pharma Stock Fundamentals & Key Indicators

Check IGC Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$29.1M

EPS (TTM)

-0.0823

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.42

Industry PE ratio

-2.65

PEG Ratio

0.3536150920120095

EBITDA

-7.4M

Revenue (TTM)

1.1M

Profit Margin

21.91%

Return On Equity TTM

-113.58%

IGC Pharma Stock Valuation

Track how IGC Pharma P/E has moved over time to understand its valuation trends.

IGC Pharma in the last 5 years

Overview
Trends

Lowest (-3.64x)

March 31, 2026

Today (-3.64x)

March 31, 2026

Industry (-2.65x)

March 31, 2026

Highest (-1.55x)

June 30, 2023

LowHigh

Today’s Price to Earnings Ratio: -3.64x

IGC Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of IGC Pharma with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
IGC Pharma	Buy	$29.1M	-81.54%	-3.42	21.91%	0.00%
Moderna	Neutral	$77.8B	-53.76%	-24.41	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$132.4B	186.58%	30.16	86.04%	0.00%
Regeneron	Buy	$82.8B	23.34%	19.01	84.86%	0.46%

Stock Returns calculator for IGC Pharma Stock including INR - Dollar returns

The IGC Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

IGC Pharma investment value today

Current value as on today

₹76,644

Returns

-₹23,356

(-23.36%)

Returns from IGC Pharma Stock

-₹28,992 (-28.99%)

Dollar Impact

₹5,636 (+5.64%)

Analyst Recommendation on IGC Pharma Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for IGC Pharma. Average target price of $6

IGC Pharma Share Price Target

Get share price movements and forecasts by analysts on IGC Pharma.

What analysts predicted

95.29%UPSIDE

Target Price

Current Price

$0.2824

Analyzed by

5 Analysts

Target

$6.00

IGC Pharma target price $6, a slight upside of 95.29% compared to current price of $0.2824. According to 5 analysts rating.

Indian Investors' Interest in IGC Pharma Stock

Search interest for IGC Pharma Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 27, 2026 to September 26, 2026

Change:20% versus previous 30 day period

IGC Pharma Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-2	-2	-1	-1	-1	-1	-2	-2	-2	-2
EBITDA	-2	-2	-1	-1	-1	-1	-1	0	-2	-2
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-2	-1	-1	-1	-1	-1	0	-2	-2
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-2	-2	-1	-1	-1	-1	-1	0	-2	-2
Net Profit Margin	8.47%	59.93%	48.06%	40.47%	46.67%	46.95%	51.83%	12.57%	17.35%	18.11%

IGC Pharma Annual Profit & Loss

All numbers in Millions USD

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Jun 2023	Mar 2024	Mar 2025	Mar 2026
Total Revenue	0	2	5	4	0	0	0	1	1	1
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-2	-1	-4	-6	-8	-15	-11	-9	-7	-10
EBITDA	-1	-1	-4	-6	-8	-14	-10	-12	-6	-6
Interest Expense	0	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-4	-7	-8	-15	-11	-13	-7	-6
Income Tax Expense	0	0	0	-	-	-	-	-	-	-
Net Income	-1	-1	-4	-7	-8	-15	-11	-13	-7	-6
Net Profit Margin	37.60%	3.72%	2.58%	2.82%	-38.86%	48.87%	-17.34%	54.50%	48.70%	29.68%

IGC Pharma Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-2	-2	-1	-1	-1	-1	-1	0	-2	-2
Operating Cash Flow	0	-1	0	-1	0	-1	-2	-1	-1	-1
Investing Cash Flow	0	0	0	0	0	0	0	0	0	0
Financing Cash Flow	0	2	0	0	0	0	3	1	0	1
Change in Cash	0	0	0	-1	0	0	0	0	0	0

IGC Pharma Annual Cash Flow

All numbers in Millions USD

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Jun 2023	Mar 2024	Mar 2025	Mar 2026
Net Income	-1	-1	-4	-7	-8	-15	-11	-13	-7	-6
Operating Cash Flow	-1	-1	-3	-8	-10	-7	-7	-5	-4	-5
Investing Cash Flow	0	0	0	-9	3	0	0	0	0	0
Financing Cash Flow	0	3	27	0	14	4	0	3	4	5
Change in Cash	0	1	23	-18	7	-4	-7	-1	0	0

Mutual Funds that own IGC Pharma Stock

Check out the Mutual Funds with significant holdings in IGC Pharma.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	0.694919%	718436
Fidelity Concord Street Trust	0.628155%	649412

Global Institutional Holdings in IGC Pharma

Funds	Holdings
AdvisorShares	0.86%
Vanguard	0.79%
VANGUARD INDEX FUNDS	0.69%
Fidelity Concord Street Trust	0.63%
Ken Fisher	0.04%

IGC Pharma News & Key Events

Insights on IGC Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, IGC stock has moved up by 7.4%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 741.1%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 102.7% return, outperforming this stock by 120.2%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 350.0K → 265.0K (in $), with an average decrease of 12.9% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -726.0K → -2.93M (in $), with an average decrease of 126.5% per quarter

About IGC Pharma

IGC Pharma, Inc. operates as a pharmaceutical firm, currently in the clinical development phase, dedicated to pioneering novel treatments for Alzheimer's, a debilitating condition. The company's pipeline includes two experimental drug candidates aimed at this disease: IGC-AD1, which is presently undergoing a Phase 2 clinical study for addressing agitation associated with Alzheimer's-related dementia, and TGR-63, which is still in its preclinical stage. Beyond its therapeutic development efforts, IGC Pharma also explores the application of artificial intelligence (AI) to advance Alzheimer's research. Established on April 29, 2005, by Ram Mukunda, the company maintains its principal office in Potomac, Maryland.

Organisation	IGC Pharma
Headquarters	10224 Falls Road, Potomac, MD, 20854, US
Industry	Biotechnology
CEO	Ram Mukunda
E-voting on shares	Click here to vote

Key Management of IGC Pharma

Name	Title
Ms. Claudia Grimaldi	VP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director
Benysh Qureshi Esq., M.B.A.	Director of Operations
Mr. Rohit Goel CPA, M.B.A.	Director of Accounting & Senior Director
Susana Salgar	Sales Manager
Mr. Ram Mukunda	Founder, President, CEO & Director

FAQs

What is IGC Pharma share price today?

IGC Pharma share price today is $0.28 as on September 26, 2026 at 8:45 am IST at the close of the market. IGC Pharma share today touched a day high of $0.29 and a low of $0.28.

What is the 52 week high and 52 week low for IGC Pharma share?

IGC Pharma share touched a 52 week high of $0.45 on November 3, 2025 and a 52 week low of $0.24 on July 29, 2026. IGC Pharma stock price today i.e. September 26, 2026 at 8:45 am IST is closed at $0.28,which is 37.36% down from its 52 week high and 20.17% up from its 52 week low.

What is IGC Pharma's market capitalisation today?

IGC Pharma market capitalisation is $0.00T as on September 26, 2026 at 8:45 am IST.

How to invest in IGC Pharma Stock (IGC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for IGC Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in IGC Pharma Shares that will get you 5.3116 shares as per IGC Pharma share price of $0.28 per share as on September 26, 2026 at 8:45 am IST.

What is the minimum amount required to buy IGC Pharma Stock (IGC) from India?

Indian investors can start investing in IGC Pharma (IGC) shares with as little as ₹95.8125 or $1 (as of September 26, 2026 at 12:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in IGC Pharma stock (as per the Rupee-Dollar exchange rate as on September 26, 2026 at 12:42 pm IST). Based on IGC Pharma share’s latest price of $0.28 as on September 26, 2026 at 8:45 am IST, you will get 35.4108 shares of IGC Pharma. Learn more about fractional shares .

What are the returns that IGC Pharma has given to Indian investors in the last 5 years?

IGC Pharma stock has given -81.54% share price returns and 29.49% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?